ZC3-11280-14066 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-07
Dose 1 — Moderna
2021-02-06
Dose 2 — Moderna
2021-02-07
Registered in v-safe
2021-02-07
Health check-in — days 1–6 daily, dose 2
Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Vomiting · Be unable to work, Be unable to do your normal daily activities

Adult check-in
2021-02-07
Report sent to call center — days 1–6 daily, dose 2
Be unable to work · Be unable to do your normal daily activities

1 call case(s)
2021-02-08
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Site: Pain · Fatigue or tiredness

Adult check-in
2021-02-09
Survey response — days 1–6 daily, dose 2
MedDRA: Muscle fatigue, Muscular weakness — Feeling: Good · Site: Pain · Fatigue or tiredness, Nausea

Free text: Muscle fatigue/weakness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-11
Health check-in — days 1–6 daily, dose 2
Feeling: Good · Site: Pain · None

Adult check-in
2022-02-08
Health check-in — 12 months, dose 2
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-07	Moderna
2	2021-02-06	Moderna

Call center

Reported	Outcome	VAERS-related outcome
2021-02-07	priority 2/3

Free text

Release 3 — days 1–6 daily, dose 2

2021-02-09

Systemic reaction (other): Muscle fatigue/weakness

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SRO	Muscle fatigue	✓	✓	✓
SRO	Muscular weakness	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release